The Clinical Development and Operations team at Annexon Biosciences is responsible for designing and executing clinical trials to evaluate the safety and efficacy of their innovative complement medicines. This team collaborates across various functions, including regulatory affairs, data management, and biostatistics, to ensure that all clinical programs are conducted according to regulatory standards and timelines, ultimately aiming to bring groundbreaking therapies to patients with severe autoimmune and neurodegenerative disorders.
AJ Acker
Senior Vice President, Regulat...
Behn Sarafpour
Vice President Medical Affairs
Benjamin Douglass Ho...
Clinical Development Leader
Brienna Campbell
Director, Strategic Clinical O...
Cecilia Oliyai
Senior Vice President CMC Oper...
Dean Richard Artis
EVP And Chief Scientific Offic...
Harman Hansra
Sr. Director, Global Clinical ...
Jeannette Osterloh
Director, Portfolio Strategy &...
Justin Chun
Senior Manager, CMC Operations
Yaisa S. Andrews-Zwi...
VP, Global Program Team Leader
View all